Chronic Obstructive Pulmonary Disease and U.S. Workers: Prevalence, Trends, and Attributable Cases Associated With Work.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
09 2021
Historique:
received: 14 01 2021
revised: 16 04 2021
accepted: 19 04 2021
entrez: 22 8 2021
pubmed: 23 8 2021
medline: 7 9 2021
Statut: ppublish

Résumé

Chronic obstructive pulmonary disease is the fourth leading cause of death in the U.S. Workplace exposures are important modifiable contributors to the burden of chronic obstructive pulmonary disease. Among U.S. workers, 19% of chronic obstructive pulmonary disease cases are attributable to workplace exposures. This study examines the trends in chronic obstructive pulmonary disease prevalence during 2012-2018 among workers and assesses the population attributable fraction for chronic obstructive pulmonary disease associated with work by smoking status, industry, and occupation. The 2012-2018 National Health Interview Survey data for workers aged ≥18 years employed during the 12 months before the interview were analyzed in 2019. Annual trends were examined using the Poisson regression model. Multivariate logistic regression was used to calculate adjusted prevalence ORs. During 2012-2018, an estimated age-adjusted annual average of 4.1% of workers had chronic obstructive pulmonary disease, and prevalence varied by industry and occupation. Overall, chronic obstructive pulmonary disease prevalence increased by an estimated annual average of 1.5% (p<0.05). The prevalence trends increased significantly among workers in the merchant wholesale nondurable and the arts, entertainment, and recreation industries and among financial specialists; supervisors, other food services workers; supervisors, building grounds workers, and maintenance workers; personal care and services workers; supervisors and office and administrative support workers; and motor-vehicle operators and material moving workers. The proportion of chronic obstructive pulmonary disease cases attributable to work was 27.3% among all workers and 24.0% among never smokers. Public health efforts to increase the awareness and understanding of chronic obstructive pulmonary disease associated with occupational risk factors are needed to prevent chronic obstructive pulmonary disease among workers, especially among those employed in industries and occupations with increasing prevalence trends.

Identifiants

pubmed: 34419236
pii: S0749-3797(21)00265-8
doi: 10.1016/j.amepre.2021.04.011
pmc: PMC8672326
mid: NIHMS1762390
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e127-e137

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Published by Elsevier Inc.

Références

Prev Chronic Dis. 2020 Nov 19;17:E144
pubmed: 33211997
Am J Ind Med. 2013 Jun;56(6):635-46
pubmed: 22821700
J Occup Environ Med. 2008 Mar;50(3):366-70
pubmed: 18332787
J Asthma. 2012 Feb;49(1):2-4
pubmed: 21895566
Chest. 2015 Jan;147(1):31-45
pubmed: 25058738
Public Health Rep. 2017 Mar/Apr;132(2):149-156
pubmed: 28135423
Am J Epidemiol. 2002 Oct 15;156(8):738-46
pubmed: 12370162
Thorax. 2009 Jan;64(1):6-12
pubmed: 18678700
MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):809-814
pubmed: 32614807
MMWR Morb Mortal Wkly Rep. 2012 Nov 23;61(46):938-43
pubmed: 23169314
Chest. 2011 Apr;139(4):752-763
pubmed: 20884729
BMC Pulm Med. 2014 Mar 21;14:49
pubmed: 24650114
JAMA Netw Open. 2019 Oct 2;2(10):e1913563
pubmed: 31626315
MMWR Morb Mortal Wkly Rep. 2019 Apr 05;68(13):303-307
pubmed: 30946736
Br Med Bull. 2012;104:143-61
pubmed: 23080418
Thorax. 2005 Aug;60(8):645-51
pubmed: 16061705
Eur Respir J. 2019 Jul 18;54(1):
pubmed: 31248951
J Occup Environ Med. 2008 May;50(5):561-9
pubmed: 18469625
Environ Health. 2006 Feb 14;5:2
pubmed: 16476167
Am J Respir Crit Care Med. 2007 Nov 15;176(10):994-1000
pubmed: 17626912
Nicotine Tob Res. 2015 May;17(5):599-606
pubmed: 25239956
MMWR Morb Mortal Wkly Rep. 2017 Oct 27;66(42):1130-1135
pubmed: 29072865
COPD. 2014 Feb;11(1):88-95
pubmed: 24111617
PLoS One. 2017 Mar 8;12(3):e0171494
pubmed: 28273094
J Occup Environ Med. 2014 Oct;56(10):1088-93
pubmed: 25285832
Eur Respir J. 2003 Sep;22(3):462-9
pubmed: 14516136
MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):289-95
pubmed: 25811677
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1312-1334
pubmed: 31149852
Am J Respir Crit Care Med. 2003 Mar 1;167(5):787-97
pubmed: 12598220

Auteurs

Girija Syamlal (G)

Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia. Electronic address: gos2@cdc.gov.

Brent Doney (B)

Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia.

Scott Hendricks (S)

Division of Safety Research, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia.

Jacek M Mazurek (JM)

Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH